T Cell Responses to Canine Factor IX and AAV Capsid Antigens in Hemophilia B Dogs after Intravascular Gene Delivery to Skeletal Muscle

被引：0
|
作者：
Hui, Daniel J. [1 ]
Mingozzi, Federico [1 ]
Dillow, Aaron [2 ]
McCorquodale, Stephanie [2 ]
Nichols, Timothy C. [2 ]
Arruda, Valder R. [1 ]
High, Katherine A. [1 ]
机构：
[1] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[2] Univ N Carolina, Chapel Hill, NC USA
来源：
MOLECULAR THERAPY | 2006年 / 13卷
关键词：
D O I：
10.1016/j.ymthe.2006.08.1188
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
1086
引用
收藏
页码：S417 / S417
页数：1
相关论文
共 33 条
  • [1] Characterization of the immune response to canine factor IX following AAV-mediated intravascular gene delivery to skeletal muscle in hemophilia B dogs.
    Hui, DJ
    Mingozzi, F
    Sabatino, DE
    Mccorquodale, S
    Dillow, A
    Nichols, TC
    Arruda, VR
    High, KA
    [J]. BLOOD, 2005, 106 (11) : 377A - 377A
  • [2] Safety of AAV Factor IX Peripheral Transvenular Gene Delivery to Muscle in Hemophilia B Dogs
    Haurigot, Virginia
    Mingozzi, Federico
    Buchlis, George
    Hui, Daniel J.
    Chen, Yifeng
    Basner-Tschakarjan, Etiena
    Arruda, Valder R.
    Radu, Antoneta
    Franck, Helen G.
    Wright, J. Fraser
    Zhou, Shangzhen
    Stedman, Hansell H.
    Bellinger, Dwight A.
    Nichols, Timothy C.
    High, Katherine A.
    [J]. MOLECULAR THERAPY, 2010, 18 (07) : 1318 - 1329
  • [3] Correction of canine hemophilia B phenotype by intravascular delivery of AAV vector to skeletal muscle.
    Arruda, VR
    Schuettrumpf, J
    Nichols, TC
    Herzog, RW
    Haskins, M
    Couto, LB
    Stedman, H
    High, KA
    [J]. BLOOD, 2001, 98 (11) : 781A - 782A
  • [4] AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B
    Manno, CS
    Chew, AJ
    Hutchison, S
    Larson, PJ
    Herzog, RW
    Arruda, VP
    Tai, SJ
    Ragni, MV
    Thompson, A
    Ozelo, M
    Couto, LB
    Leonard, DGB
    Johnson, FA
    McClelland, A
    Scallan, C
    Skarsgard, E
    Flake, AW
    Kay, MA
    High, KA
    Glader, B
    [J]. BLOOD, 2003, 101 (08) : 2963 - 2972
  • [5] Factor IX expression in skeletal muscle of a severe hemophilia B patient 10 years after AAV-mediated gene transfer
    Buchlis, George
    Podsakoff, Gregory M.
    Radu, Antonetta
    Hawk, Sarah M.
    Flake, Alan W.
    Mingozzi, Federico
    High, Katherine A.
    [J]. BLOOD, 2012, 119 (13) : 3038 - 3041
  • [6] Evidence of multiyear factor IX expression by AAV-mediated gene transfer to skeletal muscle in an individual with severe hemophilia B
    Jiang, Haiyan
    Pierce, Glenn F.
    Ozelo, Margareth C.
    de Paula, Erich V.
    Vargas, Joseph A.
    Smith, Peter
    Summer, Juerg
    Luk, Alvin
    Manno, Catherine S.
    High, Katherine A.
    Arruda, Valder R.
    [J]. MOLECULAR THERAPY, 2006, 14 (03) : 452 - 455
  • [7] Gene therapy for hemophilia B: AAV-mediated transfer of the gene for coagulation factor IX to human muscle
    Larson, PJ
    High, KA
    [J]. HEMOPHILIA CARE IN THE NEW MILLENNIUM, 2001, 489 : 45 - 57
  • [8] Regional intravascular delivery of AAV-2-F.IX to skeletal muscle achieves long-term correction of hemophilia B in a large animal model
    Arruda, VR
    Stedman, HH
    Nichols, TC
    Haskins, ME
    Nicholson, M
    Herzog, RW
    Couto, LB
    High, KA
    [J]. BLOOD, 2005, 105 (09) : 3458 - 3464
  • [9] AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B (vol 101, pg 2963, 2003)
    Manno
    [J]. BLOOD, 2003, 102 (03) : 788 - 788
  • [10] Role of the vector genome and underlying factor IX mutation in immune responses to AAV gene therapy for hemophilia B
    Geoffrey L Rogers
    Ashley T Martino
    Irene Zolotukhin
    Hildegund CJ Ertl
    Roland W Herzog
    [J]. Journal of Translational Medicine, 12
1234